# NVE Corp: Form 10-Q for the period ended Jun 30, 2009

- Company: [NVE Corp](/companies/nvec.md) (CIK 724910)
- Form: 10-Q
- Filed: 2009-07-22
- Accepted by EDGAR: Jul 22, 2009, 16:13 ET
- Period: 2009-06-30
- Accession: 0000724910-09-000012
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/724910/000072491009000012/q1q10.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/724910/000072491009000012/

## Management's discussion and analysis

As filed, 7,543 characters.

### Forward-looking statements

Some of the statements made in this Report or in the documents incorporated by reference in this Report and in other materials filed or to be filed by us with the Securities and Exchange Commission (“SEC”) as well as information included in verbal or written statements made by us constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to the safe harbor provisions of the reform act. Forward-looking statements may be identified by the use of the terminology such as may, will, expect, anticipate, intend, believe, estimate, should, or continue, or the negatives of these terms or other variations on these words or comparable terminology. To the extent that this Report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of NVE, you should be aware that our actual financial condition, operating results and business performance may differ materially from that projected or estimated by us in the forward-looking statements. We have attempted to identify, in context, some of the factors that we currently believe may cause actual future experience and results to differ from their current expectations. These differences may be caused by a variety of factors, including but not limited to an uncertain economic environment, risks associated with our marketable securities, competition including entry of new competitors, progress in research and development activities by us and others, variations in costs that are beyond our control, adverse legal proceedings, lower sales, failure of suppliers to meet our requirements, failure to obtain new customers, inability to carry out marketing and sales plans, inability to meet customer technical requirements, inability to consummate license agreements, ineligibility for SBIR awards, loss of key executives, and other specific risks that may be alluded to in this Report or in the documents incorporated by reference in this Report.

Further information regarding our risks and uncertainties are contained in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended March 31, 2009.

### General

NVE Corporation, referred to as NVE, we, us, or our, develops and sells devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. We manufacture high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. We have also licensed our spintronic magnetoresistive random access memory technology, commonly known as MRAM.

### Critical Accounting Policies

A description of our critical accounting policies is provided in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended March 31, 2009. At June 30, 2009 our critical accounting policies and estimates continued to include research and development contract percentage of completion estimation, product warranty estimation, inventory valuation, allowance for doubtful accounts estimation, and deferred tax assets estimation.

### Quarter ended June 30, 2009 compared to quarter ended June 30, 2008

The table shown below summarizes the percentage of revenue and quarter-to-quarter changes for various items:

*Revenue*

| 2009 | Percentage of Revenue Quarter Ended June 30 | 2008 | Quarter- to-Quarter Change |
| --- | ---: | ---: | ---: |
| Product sales | 81.0% | 93.5% | 21.7% |
| Contract research and development | 19.0% | 6.5% | 310.9% |
| Total revenue | 100.0% | 100.0% | 40.5% |
| Cost of sales | 27.7% | 28.9% | 34.4% |
| Gross profit | 72.3% | 71.1% | 43.0% |
| Expenses |  |  |  |
| Selling, general, and administrative | 9.3% | 10.9% | 20.1% |
| Research and development | 3.9% | 8.0% | (30.8)% |
| Total expenses | 13.2% | 18.9% | (1.4)% |
| Income from operations | 59.1% | 52.2% | 59.0% |
| Interest and other income | 5.4% | 5.3% | 43.5% |
| Income before taxes | 64.5% | 57.5% | 57.6% |
| Provision for income taxes | 21.5% | 18.4% | 64.2% |
| Net income | 43.0% | 39.1% | 54.5% |

Total revenue for the quarter ended June 30, 2009 (the first quarter of fiscal 2010) increased 41% to $6,834,532 compared to $4,863,786 for the quarter ended June 30, 2008 (the first quarter of fiscal 2009). The increase was due to a 22% increase in product sales and a 311% increase in contract research and development revenue. The increase in product sales was due to increased volume from the addition of new customers and increased purchase volume by existing customers. The increase in research and development revenue was due to new contracts. The increase in research and development revenue may not be representative of future trends and there can be no assurance of additional or follow-on contracts for expired or completed contracts.

Gross profit margin increased to 72% of revenue for the first quarter of fiscal 2010 compared to 71% for the first quarter of fiscal 2009. The increase was due to higher margins on both product sales and contract research and development revenue.

Selling, general, and administrative expense for the first quarter of fiscal 2010 increased 20% compared to the first quarter of fiscal 2009, primarily due to increased salaries, increased performance-based compensation, and increased commissions.

Research and development expense decreased 31% for the first quarter of fiscal 2010 compared to the first quarter of fiscal 2009 due to an increase in contract research and development obligations, which caused resources to be reallocated from expensed research and development activities. The decrease in research and development expense may not be representative of future expense trends. Our research and development expense can fluctuate significantly depending on staffing, project requirements, and contract research and development obligations.

Interest and other income increased 44% to $370,025 for the first quarter of fiscal 2010 compared to $257,835 for first quarter of fiscal 2009. The increase was due to an increase in interest-bearing marketable securities.

The provision for income taxes was $1,471,158, or 33% of income before taxes, for the first quarter of fiscal 2010 compared to $896,057, or 32% of income before taxes, for the first quarter of fiscal 2009. The effective tax rate can fluctuate due to a number of factors, some of which are outside our control.

The 54% increase in net income in the first quarter of fiscal 2010 compared to the prior-year quarter was primarily due to increases in product sales, contract research and development revenue, and interest income.

### Liquidity and capital resources

At June 30, 2009 we had $40,618,655 in cash plus short-term and long-term marketable securities compared to $34,321,811 at March 31, 2009. Our entire portfolio of short-term and long-term marketable securities is classified as available for sale. The increase in cash plus marketable securities in the first quarter of fiscal 2010 was primarily due to $4,792,111 in net cash provided by operating activities and a $1,270,859 net increase in market value of marketable securities due to market-price increases.

Accrued payroll and other increased $1,272,624 primarily due to the accrual of Federal and state income taxes.

We currently believe our working capital is adequate for our needs at least for the next 12 months.

## Market risk

As filed, 1,023 characters.

The primary objective of our investment activities is to preserve principal while at the same time maximizing after-tax yields without significantly increasing risk. To achieve this objective, we maintain our portfolio of cash equivalents and marketable securities in a variety of securities including government agency obligations, municipal obligations, corporate obligations, and money market funds. Short-term and long-term marketable securities are generally classified as available-for-sale and consequently are recorded on the balance sheet at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income, net of estimated tax. Marketable securities as of June 30, 2009 had remaining maturities between 10 and 60 months. Our short-term and long-term marketable securities had a fair market value of $39,367,094 at June 30, 2009, representing approximately 82% of our total assets. We have not used derivative financial instruments in our investment portfolio.

## Controls and procedures

As filed, 1,280 characters.

Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has performed an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. This evaluation included consideration of the controls, processes and procedures that are designed to ensure that information required to be disclosed by us in the reports we file under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective.

During the quarter ended June 30, 2009, there was no change in our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 143 characters.

There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2009.

Filed Jul 22, 2009.
Source: SEC EDGAR, the filing index for accession 0000724910-09-000012. Last ingested by Listed: Nov 5, 2026, 19:10 ET. No prices; not investment advice.